Experiencing persistent joint pain, fatigue or unexplained rashes? These could be signs of an autoimmune condition.

The FDA has approved the SetPoint System, a neuroimmune modulation device, for the treatment of adults with moderately to severely active rheumatoid arthritis.

Researchers at Duke University School of Medicine have found that stimulating a key nerve in the body may help reduce the gut ...

The SetPoint System is an implanted device that stimulates the vagus nerve once a day. It was tested through a clinical trial at Northwell Health.

US FDA approves SetPoint Medical’s novel neuroimmune modulation device, SetPoint System for rheumatoid arthritis: Valencia, California Saturday, August 2, 2025, 17:00 Hrs [IST] ...

A first-of-its-kind implant has just been granted approval from the US Food and Drug Administration (FDA) for the treatment ...

The Food and Drug Administration has approved a vagus nerve bioimplant to treat rheumatoid arthritis (RA). The scientific ...

SetPoint Medical's vagus nerve stimulator has received FDA approval for treating moderate-to-severe rheumatoid arthritis (RA) ...

The agency’s decision was based on the outcomes of the double-blind, randomised, sham-controlled RESET-RA study.

The US Food and Drug Administration has approved a pill-sized device for treating rheumatoid arthritis, marking the first ...

The FDA has approved a medical device that stimulates the vagus nerve for the treatment of moderate-to-severe rheumatoid ...

The FDA has approved the SetPoint System, a vagus nerve stimulator from SetPoint Medical, for the treatment of rheumatoid arthritis.The device is an implantable, integrated neurostimulator about the ...